Mark S Reuben, MD | |
40 Berkshire Ct, Wyomissing, PA 19610-1224 | |
(610) 374-7400 | |
(610) 374-1641 |
Full Name | Mark S Reuben |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 40 Berkshire Ct, Wyomissing, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447251343 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD015509E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mark S Reuben, MD 40 Berkshire Ct, Wyomissing, PA 19610-1224 Ph: (610) 374-7400 | Mark S Reuben, MD 40 Berkshire Ct, Wyomissing, PA 19610-1224 Ph: (610) 374-7400 |
News Archive
Keryx Biopharmaceuticals, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 clinical program for Zerenex(TM) (ferric citrate), its iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD).
OXIS INTERNATIONAL, INC. (Pink Sheets: OXIS, Paris: OXI) announced today that Ergoplex™, its commercial anti-inflammatory product using its patented compound, Ergothioneine, a powerful antioxidant, has shown very good acceptance in a recent direct mail test.
Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., announced its results for the second quarter ended June 30, 2015.
A prestigious peer-review journal will publish an article in its January 2010 edition outlining a Vancouver BC based biomedical technology company's solution to the growing problem of hospital patients acquiring bacterial infections. The article about Enox Biopharma's self-sterilizing technology for catheters (patent pending) was accepted for publication in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology and one of the most prominent publications in the field.
Removing an extra two millimetres around an area of invasive breast cancer is sufficient to minimise any residual disease in 98 per cent of patients, according to research published in the November issue of IJCP, the International Journal of Clinical Practice.
› Verified 5 days ago
Tiffany L. Sergi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-4252 | |
Joe K. George, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Suite 1, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-4252 | |
Robert J Cordes, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2240 Ridgewood Rd, Ste 100, Wyomissing, PA 19610 Phone: 610-376-8691 Fax: 610-376-8745 | |
Sanand R. Menon, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-4252 | |
Amanda Lynn Gosling, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Suite 1, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-1641 | |
Jennifer L Watson, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Suite 1, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-1641 |